MetLife Investment Management’s Luminex Corp LMNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-18,901
Closed -$696K 2604
2021
Q2
$696K Hold
18,901
0.01% 1378
2021
Q1
$603K Hold
18,901
0.01% 1416
2020
Q4
$437K Hold
18,901
﹤0.01% 1557
2020
Q3
$496K Hold
18,901
0.01% 1372
2020
Q2
$615K Hold
18,901
0.01% 1267
2020
Q1
$520K Hold
18,901
0.01% 1199
2019
Q4
$438K Hold
18,901
﹤0.01% 1540
2019
Q3
$390K Hold
18,901
﹤0.01% 1557
2019
Q2
$390K Hold
18,901
﹤0.01% 1626
2019
Q1
$435K Hold
18,901
﹤0.01% 1541
2018
Q4
$437K Hold
18,901
0.01% 1449
2018
Q3
$573K Hold
18,901
0.01% 1448
2018
Q2
$558K Hold
18,901
0.01% 1346
2018
Q1
$398K Hold
18,901
﹤0.01% 1507
2017
Q4
$372K Buy
+18,901
New +$393K ﹤0.01% 1578

MetLife Investment Management's LMNX Position: Q3 2021 in Review

MetLife Investment Management sold out of Luminex Corp (LMNX) in Q3 2021, closing a stake of 18,901 shares — an estimated $696K sold.

MetLife Investment Management first reported a position in LMNX in Q4 2017 and held it in 15 quarters. The position peaked at $696K in Q2 2021. 1 fund tracked by Wall St. Rank holds LMNX as of Q3 2021.

  • MetLife Investment Management reported no remaining Luminex Corp position as of Q3 2021 after selling out during the quarter.
  • MetLife Investment Management sold 18,901 Luminex Corp shares in Q3 2021, an estimated $696K.
  • MetLife Investment Management first reported a position in Luminex Corp in Q4 2017 and held it in 15 quarters.
  • MetLife Investment Management's Luminex Corp position peaked at $696K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Luminex Corp as of Q3 2021.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.